Nuvectis Pharma Inc. (NVCT)
NASDAQ: NVCT
· Real-Time Price · USD
6.47
0.04 (0.62%)
At close: Aug 15, 2025, 3:59 PM
6.43
-0.62%
After-hours: Aug 15, 2025, 04:10 PM EDT
Nuvectis Pharma Ratios and Metrics
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
PE Ratio | -6.3 | -9.13 | -3.7 | -6.52 | -5.9 | -7.87 | -5.48 | -8.82 | -10.62 | -12.07 | -4.2 | -4.24 | -10 | -8.02 | -4.57 | -2.06 | -1.74 | -449.27 |
PEG Ratio | -0.64 | 0.34 | -0.07 | 0.85 | -1.47 | 0.23 | -2.03 | 3.35 | -0.26 | 0.30 | -0.59 | -0.08 | -0.46 | -0.29 | 0.08 | 0.12 | -0.00 | n/a |
PS Ratio | n/a | n/a | 3.46 | n/a | n/a | n/a | -35.42 | n/a | n/a | 47.07 | 737.04 | n/a | n/a | n/a | 10.33K | n/a | n/a | n/a |
PB Ratio | 9.46 | 9.30 | 9.53 | 9.86 | 8.34 | 9.36 | 11.91 | 12.44 | 11.92 | 15.73 | 7.72 | 4.89 | 12.39 | 6.47 | -3.75 | -4.3 | -9.39 | -1.25K |
P/FCF Ratio | -47.4 | -46.67 | -37.56 | -45.08 | -34.58 | -30.13 | -37.73 | -63.99 | -59.37 | -40.41 | -31.23 | -22.52 | -56.01 | -30.64 | -38.74 | -8.68 | -10.3 | n/a |
P/OCF Ratio | -47.4 | -46.67 | -37.56 | -45.08 | -34.58 | -30.13 | -37.73 | -63.99 | -59.37 | -40.41 | -31.23 | -22.52 | -56.01 | -30.64 | -38.74 | -8.68 | -10.3 | n/a |
OCF/S Ratio | n/a | n/a | -0.09 | n/a | n/a | n/a | 0.94 | n/a | n/a | -1.16 | -23.6 | n/a | n/a | n/a | -266.75 | n/a | n/a | n/a |
Debt / Equity Ratio | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Quick Ratio | 2.66 | 3.28 | 2.09 | 2.74 | 3.17 | 3.46 | 2.75 | 3.99 | 5.41 | 4.12 | 3.30 | 5.54 | 5.20 | 5.76 | 2.41 | 13.76 | 18.54 | n/a |
Current Ratio | 2.66 | 3.28 | 2.09 | 2.74 | 3.17 | 3.46 | 2.75 | 3.99 | 5.41 | 4.12 | 3.30 | 5.54 | 5.20 | 5.76 | 2.41 | 13.76 | 18.54 | n/a |
Asset Turnover | n/a | n/a | 1.44 | n/a | n/a | n/a | -0.21 | n/a | n/a | 0.25 | 0.01 | n/a | n/a | n/a | 0.00 | n/a | n/a | n/a |
Interest Coverage | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Return on Equity | -0.38 | -0.25 | -0.64 | -0.38 | -0.35 | -0.3 | -0.54 | -0.35 | -0.28 | -0.33 | -0.46 | -0.29 | -0.31 | -0.2 | 0.21 | 0.52 | 1.35 | 0.70 |
Return on Assets | -0.23 | -0.18 | -0.34 | -0.24 | -0.24 | -0.21 | -0.35 | -0.26 | -0.23 | -0.25 | -0.32 | -0.24 | -0.25 | -0.17 | -0.34 | -0.69 | -0.82 | n/a |
Return on Invested Capital | -0.39 | -0.27 | -0.66 | -0.4 | -0.37 | -0.31 | -0.56 | -0.37 | -0.28 | -0.33 | -0.47 | -0.29 | -0.31 | -0.2 | -0.53 | -0.74 | -0.87 | 0.70 |
Dividend Yield | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Payout Ratio | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Gross Profit Margin | n/a | n/a | 0.50 | n/a | n/a | n/a | 3.67 | n/a | n/a | 1.00 | 1.00 | n/a | n/a | n/a | 1.00 | n/a | n/a | n/a |
Net Profit Margin | n/a | n/a | -0.23 | n/a | n/a | n/a | 1.61 | n/a | n/a | -0.97 | -43.84 | n/a | n/a | n/a | -565.25 | n/a | n/a | n/a |
Pretax Profit Margin | n/a | n/a | -0.23 | n/a | n/a | n/a | 1.61 | n/a | n/a | -0.99 | -44.94 | n/a | n/a | n/a | -565.25 | n/a | n/a | n/a |
Operating Profit Margin | n/a | n/a | -0.24 | n/a | n/a | n/a | 1.67 | n/a | n/a | -1 | -45.49 | n/a | n/a | n/a | -566.25 | n/a | n/a | n/a |
FCF Margin | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
EBITDA Margin | n/a | n/a | -0.24 | n/a | n/a | n/a | 1.67 | n/a | n/a | n/a | -45.49 | n/a | n/a | n/a | -566.25 | n/a | n/a | n/a |